Why are we limiting access to opioid agonist therapies?
Can Pharm J (Ott)
.
2019 Jun 6;152(4):221-222.
doi: 10.1177/1715163519852973.
eCollection 2019 Jul-Aug.
Author
Jaris Swidrovich
1
Affiliation
1
University of Saskatchewan College of Pharmacy and Nutrition, Saskatoon, Saskatchewan.
PMID:
31320954
PMCID:
PMC6610507
DOI:
10.1177/1715163519852973
No abstract available